Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Des-γ-carboxy Prothrombin (PIVKA-II)-producing Mediastinal Embryonal Carcinoma with Features of Hepatoid Differentiation

YASUYUKI HASEGAWA, KATSUYUKI TOMITA, KIYOSHI HASHIMOTO, YASUSHI SHIGEOKA, MASANARI WATANABE, AKIRA YAMASAKI and EIJI SHIMIZU
Anticancer Research November 2005, 25 (6C) 4569-4571;
YASUYUKI HASEGAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATSUYUKI TOMITA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tomo223{at}cyber.ocn.ne.jp
KIYOSHI HASHIMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUSHI SHIGEOKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASANARI WATANABE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIRA YAMASAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EIJI SHIMIZU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The case of a 48-year-old man with primary nonseminomatous embryonal carcinoma at the posterior mediastinum is described. The patient displayed extremely high plasma levels of Des-γ-carboxy prothrombin (PIVKA-II) (4040 mAU/ml). Ultrasonography and dynamic computed tomography ruled out hepatocellular carcinoma (HCC) or liver metastasis. After preoperative systemic chemotherapy, total tumor resection was performed. Postoperatively, the plasma levels of PIVKA-II returned to within the normal range (24 mAU/ml). An immnohistochemical study using anti-PIVKA-II monoclonal antibody revealed the cytoplasmic expression of PIVKA-II in the carcinoma cells. These results indicate that tumor cells, which are manifested as hepatoid differentiation, may produce PIVKA-II. This case seems to be the first case reported in which PIVKA-II was produced by nonseminomatous mediastinal embryonal carcinoma without HCC or liver metastasis.

  • Des-γ-carboxy prothrombin (PIVKA-II)
  • mediastinal embryonal carcinoma
  • hepatoid differentiation

Footnotes

  • Received July 28, 2005.
  • Accepted September 1, 2005.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 6C
1 Nov 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Des-γ-carboxy Prothrombin (PIVKA-II)-producing Mediastinal Embryonal Carcinoma with Features of Hepatoid Differentiation
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 14 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Des-γ-carboxy Prothrombin (PIVKA-II)-producing Mediastinal Embryonal Carcinoma with Features of Hepatoid Differentiation
YASUYUKI HASEGAWA, KATSUYUKI TOMITA, KIYOSHI HASHIMOTO, YASUSHI SHIGEOKA, MASANARI WATANABE, AKIRA YAMASAKI, EIJI SHIMIZU
Anticancer Research Nov 2005, 25 (6C) 4569-4571;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Des-γ-carboxy Prothrombin (PIVKA-II)-producing Mediastinal Embryonal Carcinoma with Features of Hepatoid Differentiation
YASUYUKI HASEGAWA, KATSUYUKI TOMITA, KIYOSHI HASHIMOTO, YASUSHI SHIGEOKA, MASANARI WATANABE, AKIRA YAMASAKI, EIJI SHIMIZU
Anticancer Research Nov 2005, 25 (6C) 4569-4571;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Laparotomy After Total Pelvic Exenteration: Current Status and Techniques for Ileal Conduit Preservation
  • Pregabalin for Opioid-resistant Neuropathic Pain in Bone Metastases
  • Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire